Moderna, Inc. MRNA

Actuellement 2 haussiers, 1 baissiers — de plus en plus polarisé.

Les analystes restent stables à 2 haussiers contre 1 baissiers.

3 analystes YouTube couvrent Moderna, Inc. (MRNA).

3 analystes ont couvert MRNA jusqu’à présent…

Avis des analystes

StockCharts TV7d ago

BULL$MRNACourtTechnique

le franchissement de la résistance à $58 jusqu'à $62 signale un retournement.

MRNA franchit la résistance à $58 et clôture à $62, avec un double plancher et un volume élevé qui annoncent un changement de tendance potentiel.

Après avoir formé un double plancher, MRNA a maintenu son support et a franchi la résistance aujourd'hui, clôturant près de $62 et dépassant les précédents sommets autour de $58. Ce mouvement technique, surtout si les capitaux se déplacent vers les secteurs défensifs, soutient un scénario haussier.

"This Market Rally Faces A Big Test"

Jack Corsellis43d ago

BULL$MRNACourtTechnique

Bullish on $MRNA: ORB works in flush/EMA contexts — avoided when the setup is near “extended/no-no” index conditions.

MRNA can fit the ORB framework when the indexes are flushing and the stock is near key daily moving averages, because the “no-no” zones are described as occurring when the index is extended the other way.

MRNA is framed as a tradable ORB candidate specifically when the index action lines up with mean-reversion and snapback behavior around daily moving averages. The risk note is contextual: the approach warns against taking the same type of setups when the index tape is in the unfavorable “no-no” state.

"The Trading Session That Nearly Ruined My Month (+17% Recovery)"

Valuetainment48d ago

BEAR$MRNA

next-gen shot framed as ongoing pathogen risk signal

MRNA appears to be preparing next-generation mRNA shots related to this “antivirus” threat (citing work from 2024 with Korea University), which he frames as evidence the vaccine program is implicitly tied to ongoing pathogen risk.

Next-generation mRNA vaccine development tied to 2024 research with Korea University is framed as implicit evidence that the vaccine program is linked to continuing pathogen risk rather than a standalone commercial opportunity.

""Mass Negligent Homicide" - Hantavirus Outbreak Surges As Fauci Deadline Nears"

Aucun dépôt officiel n’est encore apparu pour MRNA.